Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blue light could spot bladder tumors white light misses

NCT ID NCT02660645

Diagnosis Sponsor: Photocure Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry study is gathering information on how well blue light cystoscopy with Cysview detects bladder cancer compared to standard white light cystoscopy. About 4400 adults with suspected or known non-muscle invasive bladder cancer will take part. The goal is to see if the blue light technique finds more tumors and helps guide more complete removal.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hexaminolevulinate hydrochloride (Cysview) instilled in the bladder, used with a blue light cystoscopy device
What this could lead to
If successful, this could confirm that blue light cystoscopy with Cysview finds more bladder tumors than standard white light cystoscopy, leading to better detection and treatment.
What could go wrong
This is an observational registry, not a controlled trial, so results may not prove cause and effect. False positives could lead to unnecessary biopsies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 4,400 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Apr 2014

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients indicated for transurethral resection of the bladder.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult \>18 years old * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy Exclusion Criteria: * Porphyria * Gross hematuria * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    22 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Charleston Area Medical Center

    TERMINATED

    Charleston, West Virginia, 25301, United States

  • Emory University School of Medicine

    RECRUITING

    Atlanta, Georgia, 30097, United States

  • Indiana University School of Medicine

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Johns Hopkins Medicine

    RECRUITING

    Baltimore, Maryland, 21224, United States

  • Lexington Medical Center

    RECRUITING

    West Columbia, South Carolina, 29169, United States

  • Mayo Clinic

    RECRUITING

    Phoenix, Arizona, 85054, United States

  • Michael E. DeBakey VA Medical Center

    RECRUITING

    Houston, Texas, 77030, United States

  • NYU Langone's Perlmutter Cancer Center

    RECRUITING

    New York, New York, 10016, United States

  • Northshore University Health System

    RECRUITING

    Evanston, Illinois, 60201, United States

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Ohio State University Wexner Medical Center

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Sibley Memorial Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20016, United States

  • Stony Brook Urology

    SUSPENDED

    Stony Brook, New York, 11794, United States

  • The University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35294, United States

  • USC/Norris Comprehensive Cancer Center

    RECRUITING

    Los Angeles, California, 90033, United States

  • UT Southwestern

    RECRUITING

    Dallas, Texas, 75390, United States

  • University of California Los Angeles

    RECRUITING

    Los Angeles, California, 90095, United States

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

  • University of Kansas Medical Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

  • University of Washington Medicine

    RECRUITING

    Seattle, Washington, 98195, United States

  • VA Palo Alto Health Care System

    RECRUITING

    Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.